Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work. Today, at Ignite, Microsoft announced the general availability of SQL ...

Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...

Welcome to this afternoon session with Recursion. My name is Andrew Pucher. I'm part of the Healthcare Investment Banking team, and I'm joined by Ben Taylor, CFO of Recursion; and Sara Sherman, Head ...

Advanced SQL toolkit featuring recursive CTEs, window functions, JSON parsing, dynamic pivoting, lateral joins, and query optimization for scalable, high-performance data analytics and MAANG-level ...

We’re excited to announce a new migration capability in Azure Arc to simplify and accelerate SQL Server migration. This new capability, now generally available, is powered by Azure Database Migration ...

At Build 2025, SQL Server 2025 officially entered public preview. As one of the world’s most popular databases, this release continues a decades-long history of innovation with features made for ...

A step-by-step guide to deploying, configuring, and testing a multi-AZ, multi-region SQL Server FCI in the Azure cloud, complete with a PowerShell script that handles the networking configuration.